SAB Biotherapeutics, Inc.
SABS
$2.23
$0.3518.62%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -38.10% | -31.71% | -18.55% | -15.28% | -22.11% |
| Total Receivables | -61.09% | -43.30% | -56.87% | 16.41% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 15.06% | 45.96% | 0.48% | -24.86% | 15.39% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -31.50% | -26.88% | -17.80% | -15.70% | -20.30% |
|
|
|||||
| Total Current Assets | -31.50% | -26.88% | -17.80% | -15.70% | -20.30% |
| Net Property, Plant & Equipment | 7.29% | -3.97% | -4.79% | -3.72% | -8.32% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -6.70% | -6.28% | -1.40% | -5.83% | 58.20% |
| Total Assets | -13.75% | -17.85% | -13.08% | -13.28% | -14.97% |
|
|
|||||
| Total Accounts Payable | 48.72% | 30.66% | 10.73% | -5.53% | 31.08% |
| Total Accrued Expenses | 10.65% | -20.45% | 36.12% | -2.32% | -22.68% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 32.69% | 54.72% | -56.70% | -19.91% | -18.35% |
| Total Finance Division Other Current Liabilities | -- | -- | 0.00% | -69.64% | -71.43% |
| Total Other Current Liabilities | -- | -- | 0.00% | -69.64% | -71.43% |
| Total Current Liabilities | 20.98% | -9.49% | 16.74% | -9.07% | -23.20% |
|
|
|||||
| Total Current Liabilities | 20.98% | -9.49% | 16.74% | -9.07% | -23.20% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 47.93% | -3.46% | -3.28% | 4.89% | -2.86% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -78.82% | 56.49% | -0.15% | -35.16% | -46.44% |
| Total Liabilities | -8.30% | 7.88% | 7.12% | -14.97% | -30.37% |
|
|
|||||
| Common Stock & APIC | 0.39% | 0.42% | 0.68% | 0.39% | 0.42% |
| Retained Earnings | -4.19% | -10.10% | -10.10% | -7.71% | -5.58% |
| Treasury Stock & Other | 0.42% | -3.43% | 1.50% | 0.57% | -1.64% |
| Total Common Equity | -17.57% | -29.63% | -19.99% | -12.69% | -7.81% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -17.57% | -29.63% | -19.99% | -12.69% | -7.81% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -17.57% | -29.63% | -19.99% | -12.69% | -7.81% |
|
|
|||||